价格

B. Braun Melsungen AG

ACTIVE

Carl-Braun-Str. 1, Melsungen, Hessen, 德国www.bbraun.com/en.htmlSubsidiary10,001+ 名员工成立于: 1839-01-01

别名:

b. braun melsungen aktiengesellschaft

隶属于 b. braun holding gmbh & co. kg

概览

试验阶段分布

阶段

试验数

占比

1 期

17.9%

不适用

16.4%

3 期

14.9%

4 期

11.9%

2 期

1.5%

试验状态分布

进行中（未招募）

28.4%

已完成

62.7%

招募中

1.5%

终止

6.0%

撤回

1.5%

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

CANADA

Health Canada

药物批准

PHILIPPINES

Philippines FDA

药物批准

SFDA

Saudi Food and Drug Authority

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

Nutriflex� Lipid Peri Novo Emulsion for Infusion

NPRA

2025-12-25

Nutriflex� Omega Peri Novo Emulsion for Infusion

NPRA

2025-12-25

Etomidate Medium and Long Chain Fat Emulsion Injection

NMPA

2025-12-17

B. BRAUN COMPOUND SODIUM LACTATE IV INFUSION BP (HARTMANN'S SOLUTION)

NPRA

2025-11-29

B. BRAUN 8.4% SODIUM BICARBONATE IV INFUSION BP (100ML)

NPRA

2025-11-28

B. BRAUN WATER FOR INJECTIONS BP (10ML)

NPRA

2025-11-28

PROPOFOL-LIPURO 1% (20ML GLASS AMPOULE)

Oxynorm 10mg/ml Solution for Injection or Infusion

NPRA

2025-11-28

Nutriflex� Omega Special Novo Emulsion for Infusion

NPRA

2025-11-28

资讯

暂无资讯文章

返回机构列表

B. Braun Melsungen AG

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（67）

BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon"

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

Pragmatic, controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in trauma patients

药物批准

按机构分类的批准

近期批准

资讯